Abstract:Giant plasma membrane vesicles (GPMVs) have been utilized as a model to study phase separation in the plasma membrane. Additionally, GPMVs have been employed as vehicle for delivering molecular cargo, including small molecule drugs and nanoparticles. Nearly all examples of GPMV production use a defined salt buffer that is a stark contrast to typical cell culture medium. In this study, we demonstrate that the addition of formaldehyde and dithiothreitol to a standard culture medium was capable of generating GPMVs at a concentration equal to or higher than the traditional production buffer. These methods were evaluated for two human cell lines: kidney endothelial and Schwann cells (SCs). Morphological properties of the resultant GPMVs exhibited no significant differences between the two formulations. Factors such as pH and seeding density significantly influenced the production of GPMVs in both mediums. The cell type and seeding density was shown to influence the number of GPMVs to the greatest extent. SCs yield more GPMVs at higher seeding densities compared to endothelial cells. Stability of the membrane of the GPMVs produced in both mediums was evaluated by monitoring passive diffusion of two fluorescently tagged dextrans (3 and 10 kDa). Regardless of the production formulation or cell type, approximately 85% GPMVs are impermeable to either dextran. Cold storage for on-demand use and shipping are essential for broader use of GPMVs. Toward this aim, we have evaluated the GMPV number and morphologies following storage at -80 °C and in liquid nitrogen. A significant loss of the GPMV number, ∼30%, was observed following storage across production formulations as well as cell types. Our results indicate that smaller GMPVs, <5 μm are more stable for preservation. In conclusion, GPMVs can be produced in a broad range of formulations, exhibit a high degree of stability, and can undergo cold storage for further adoption.

Giant vesicles form in physiological saline and encapsulate pDNA by the modified electroformation method

Electroformation of giant unilamellar vesicles from large liposomes

Preparation of Giant Vesicles Encapsulating Microspheres by Centrifugation of a Water-in-oil Emulsion

Cell Line and Media Composition Influence the Production of Giant Plasma Membrane Vesicles

Insights into the mechanisms of electromediated gene delivery and application to the loading of giant vesicles with negatively charged macromolecules

Membrane-tension-dominated growth mechanism and size modulation of giant unilamellar vesicles in electroformation

Electroformation of Giant Unilamellar Vesicles from Damp Films in Conditions Involving High Cholesterol Contents, Charged Lipids, and Saline Solutions

Formation of Giant Unilamellar Vesicles Assisted by Fluorinated Nanoparticles

Construction of caged polyplexes with a reversible intracellular unpacking property to improve stability and transfection.

Cell‐derived Vesicles with Increased Stability and On‐Demand Functionality by Equipping their Membrane with a Cross‐linkable Copolymer

Electroformation in a flow chamber with solution exchange as a means of preparation of flaccid giant vesicles

Electroformation of Giant Unilamellar Vesicles from Damp Lipid Films with a Focus on Vesicles with High Cholesterol Content

Electroformation of giant vesicles from an inverse phase precursor

Multifunctional Oligomer Incorporation: a Potent Strategy to Enhance the Transfection Activity of Poly(l-Lysine)

Improved Encapsulation of DNA in pH-Sensitive Liposomes for Transfection

Architecting Multicompartmentalized, Giant Vesicles with Recombinant Fusion Proteins

Compound giant unilamellar vesicles as a bio-mimetic model for electrohydrodynamics of a nucleate cell

Formation of Giant Plasma Membrane Vesicles for Biological and Medical Applications: A Review

Giant pore formation in vesicles under msPEF-induced electroporation: role of charging time and waveform

Vesicle-based artificial cells: materials, construction methods and applications